|
2012
|
Invention
|
Phosphonic acid compounds as inhibitors of serine proteases. The present invention is directed to... |
|
2010
|
Invention
|
1,2,4-thiadiazolium derivatives as melanocortin receptor modulators. The present invention is dir... |
|
|
Invention
|
Hdm2-inhibitor complexes and uses thereof. The present invention includes crystallized HDM2 pepti... |
|
2009
|
Invention
|
Cdna encoding the human α2 δ4 calcium channel subunit. The present invention provides nucleic aci... |
|
2008
|
Invention
|
Substituted pyrazoles. Substituted pyrazoles, methods of manufacturing them, compositions contain... |
|
2007
|
Invention
|
Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat a... |
|
|
Invention
|
Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators... |
|
|
Invention
|
Combination therapy comprising glucose reabsorption inhibitors and ppar modulators. Combination t... |
|
|
Invention
|
Phenylalkynes. Substituted phenylalkynes of formula (I), compositions containing them, and method... |
|
|
Invention
|
Substituted benzimidazoles and imidazo-[4,5]-pyridines. 2-Aryl substituted benzimidazoles and imi... |
|
|
Invention
|
Neuroprotective peptides.
Methods of treating diseases of the nervous system by administration o... |
|
|
Invention
|
Substituted biphenyl carboxylic acids and derivatives thereof. 10 given below, and/or a salt or e... |
|
|
Invention
|
Substituted biphenyl carboxylic acids and derivatives thereof. The present invention relates to c... |
|
|
Invention
|
Triaryl compounds and derivates thereof. 10 given below, and solvates, hydrates, esters, and phar... |
|
|
Invention
|
Terphenyl derivatives for treatment of alzheimer' s disease. The present invention relates to com... |
|
|
Invention
|
Method of determining chymase activity with secretory leukocyte protease inhibitor. It is now dis... |
|
2006
|
Invention
|
Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods. T... |
|
|
Invention
|
Novel substituted diamine derivatives useful as motilin agonists.
The present invention relates... |
|
|
Invention
|
Nonpeptide substituted spirobenzoazepines as vasopressin antagonists. The invention is directed t... |
|
|
Invention
|
Human prss11-like s2 serine protease and uses thereof. A novel human cDNA, termed PRSS11-L, was i... |
|
|
Invention
|
Use of peptides that bind to tpo receptor. Peptide compounds that bind to and activate the thromb... |
|
|
Invention
|
Phenylalkynes. Substituted phenylalkynes of formula (I)
5 and n are as defined.
|
|
|
Invention
|
Non-imidazole aryloxyalkylamines. Substituted aryloxyalkylamines of formula (I), compositions con... |
|
|
Invention
|
Substituted amino acids as erythropoietin mimetics. This invention relates to a series of substit... |
|
|
Invention
|
Enriched antigen-specific t-cells and related therapeutic and prophylactic compositions and metho... |
|
|
Invention
|
Substituted diamine derivatives useful as motilin antagonists. The present invention relates to n... |
|
|
Invention
|
Indazole peptidomimetics as thrombin receptor antagonists. The invention is directed to novel ind... |
|
|
Invention
|
Human voltage gated sodium channel β1a subunit and methods of use. DNAs encoding human voltage ga... |
|
|
Invention
|
1,2,4-thiadiazole derivatives as melanocortin receptor modulators. The present invention is direc... |
|
|
Invention
|
Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors. The pre... |
|
2005
|
Invention
|
Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors. Aminoguanid... |
|
2002
|
Invention
|
Cdr-grafted anti-tissue factor antibodies and methods of use thereof. The present invention provi... |
|
2001
|
Invention
|
Guinea pig proteinase-activated receptor 4 and its activating peptide. This invention relates to ... |
